Toviaz, known generically as fesoterodine, is a medication used to treat overactive bladder (OAB). Finding generic alternatives involves looking for other medications that treat the same condition, as fesoterodine itself does not yet have a widely available generic version on the market in many regions, though patents may be expiring or have expired in certain jurisdictions [1].
What other medications treat overactive bladder?
Several other medications are available for treating overactive bladder symptoms, including urinary urgency, frequency, and incontinence. These include anticholinergic drugs similar to fesoterodine, as well as beta-3 adrenergic agonists. Examples of other anticholinergics used for OAB are:
* Oxybutynin (Ditropan, Ditropan XL)
* Tolterodine (Detrol, Detrol LA)
* Solifenacin (Vesicare)
* Darifenacin (Enablex)
* Trospium (Sanctura)
A beta-3 adrenergic agonist used for OAB is:
* Mirabegron (Myrbetriq)
These medications work by relaxing the bladder muscle, which helps to increase bladder capacity and reduce the sudden urge to urinate [2].
When did Toviaz patents expire?
The patent status of drugs like Toviaz can be complex, involving multiple patents that expire at different times, and patent challenges can alter these timelines. Information on specific patent expiry dates for Toviaz (fesoterodine) can often be found through specialized drug patent databases [1]. For instance, initial patent protections for fesoterodine have been addressed in litigation and patent expiry discussions, with potential for generic entry in various markets [1].
How do generic alternatives compare to Toviaz?
When a generic version of a medication becomes available, it is considered therapeutically equivalent to the brand-name drug. This means it contains the same active ingredient, dosage form, strength, and route of administration, and it works the same way in the body. Generic alternatives for OAB, whether they are other anticholinergics or a different drug class like mirabegron, offer different mechanisms of action or side effect profiles that might make them more suitable for certain patients. The choice between Toviaz and another OAB medication often depends on individual patient response, tolerability of side effects, and physician recommendation [2].
What are the potential side effects of OAB medications?
Like Toviaz, other medications for overactive bladder can cause side effects. Common side effects associated with anticholinergics, including fesoterodine, can include dry mouth, constipation, blurred vision, and cognitive impairment. Beta-3 adrenergic agonists like mirabegron may cause side effects such as increased blood pressure, urinary tract infections, and headache. Patients should discuss potential side effects with their healthcare provider to determine the best treatment option for their needs [2].
Can I switch between different OAB medications?
Switching between different overactive bladder medications is possible and often done if a patient experiences intolerable side effects or inadequate symptom control with their current treatment. Healthcare providers may recommend trying a different medication within the same drug class or switching to a medication from a different class, such as moving from an anticholinergic to a beta-3 agonist, or vice versa. This decision is made on a case-by-case basis after assessing the patient's response and overall health status [2].
---
Sources:
[1] DrugPatentWatch.com
[2] National Institute of Diabetes and Digestive and Kidney Diseases